| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
FGFR4 |
FGFR4, JTK2, TKF: Fibroblast growth factor receptor 4 precursor |
0.632 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
0.632 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
0.632 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
0.632 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
0.632 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.632 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
0.632 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.632 |
Evidence |
|
| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
IL9R |
IL9R: Interleukin-9 receptor precursor |
0.632 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CDH17 |
CDH17: Cadherin-17 precursor |
0.632 |
Evidence |
|
| JUP |
JUP, CTNNG, DP3: Junction plakoglobin |
CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
0.632 |
Evidence |
|
| MMP9 |
MMP9, CLG4B: Matrix metalloproteinase-9 precursor |
CD44 |
IPI00305064 |
0.632 |
Evidence |
O
|
| OSM |
OSM: Oncostatin-M precursor |
LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
0.632 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
0.632 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.632 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.632 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.632 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.632 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.632 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.632 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.632 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.632 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.632 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.632 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.632 |
Evidence |
|